| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | TIMM17B SLC5A10 SLC2A8 TRPM7 BAK1 KCNAB2 GRIA2 SLC10A3 AQP3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 SLC16A4 ATP6V0A4 KCNAB1 SLC37A2 TRPM1 CTNS SLC5A8 SLC7A10 ABCC10 SLC27A5 | 7.76e-09 | 1180 | 105 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | TIMM17B VMP1 SLC5A10 SLC2A8 TRPM7 BAK1 KCNAB2 GRIA2 SLC10A3 AQP3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 SLC16A4 ATP6V0A4 KCNAB1 SLC37A2 TRPM1 CTNS SLC5A8 SLC7A10 ABCC10 SLC27A5 | 9.17e-09 | 1289 | 105 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC5A10 TRPM7 KCNAB2 GRIA2 SLC10A3 AQP3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 KCNAB1 SLC37A2 TRPM1 CTNS SLC5A8 ABCC10 | 7.93e-08 | 758 | 105 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC5A10 TRPM7 KCNAB2 GRIA2 SLC10A3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 KCNAB1 TRPM1 CTNS SLC5A8 | 9.82e-07 | 627 | 105 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC5A10 TRPM7 KCNAB2 GRIA2 SLC10A3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 KCNAB1 TRPM1 SLC5A8 | 9.98e-07 | 465 | 105 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC5A10 TRPM7 KCNAB2 GRIA2 SLC10A3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 KCNAB1 TRPM1 CTNS SLC5A8 | 2.00e-06 | 664 | 105 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC2A8 GRIA2 SLC10A3 SLC6A6 SLC16A4 SLC37A2 CTNS SLC5A8 SLC7A10 SLC27A5 | 3.35e-06 | 293 | 105 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC5A10 SLC2A8 SLC10A3 SLC6A6 SLC9A2 SLC12A1 SLC16A4 SLC37A2 CTNS SLC5A8 | 3.67e-06 | 296 | 105 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC5A10 SLC2A8 SLC10A3 SLC6A6 SLC9A2 SLC12A1 SLC16A4 ATP6V0A4 SLC37A2 CTNS SLC5A8 ABCC10 | 7.86e-06 | 477 | 105 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.37e-05 | 207 | 105 | 8 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.42e-05 | 208 | 105 | 8 | GO:0005342 | |
| GeneOntologyMolecularFunction | symporter activity | 1.44e-05 | 150 | 105 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC5A10 TRPM7 KCNAB2 GRIA2 SLC10A3 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 KCNAB1 TRPM1 CTNS SLC5A8 | 1.68e-05 | 793 | 105 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.36e-05 | 171 | 105 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.93e-05 | 119 | 105 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 6.14e-05 | 15 | 105 | 3 | GO:0140161 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.82e-05 | 81 | 105 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.13e-04 | 90 | 105 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 1.29e-04 | 19 | 105 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.91e-04 | 301 | 105 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.03e-04 | 102 | 105 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.54e-04 | 167 | 105 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM7 BAK1 KCNAB2 GRIA2 AQP3 TMEM38B RYR3 KCNAB1 TRPM1 SLC5A8 | 4.54e-04 | 526 | 105 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 6.27e-04 | 32 | 105 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 6.93e-04 | 76 | 105 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 8.18e-04 | 35 | 105 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | hyalurononglucosaminidase activity | 9.63e-04 | 9 | 105 | 2 | GO:0004415 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 9.63e-04 | 9 | 105 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 9.63e-04 | 9 | 105 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.40e-03 | 42 | 105 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | channel activity | 1.80e-03 | 525 | 105 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.96e-03 | 430 | 105 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.24e-03 | 343 | 105 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.30e-03 | 105 | 105 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | integrin binding | 2.33e-03 | 175 | 105 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | BH domain binding | 2.39e-03 | 14 | 105 | 2 | GO:0051400 | |
| GeneOntologyMolecularFunction | protein antigen binding | 3.13e-03 | 16 | 105 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 3.32e-03 | 190 | 105 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 3.54e-03 | 17 | 105 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 3.54e-03 | 17 | 105 | 2 | GO:0015929 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.08e-03 | 61 | 105 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 4.42e-03 | 19 | 105 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.55e-03 | 127 | 105 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | potassium channel activity | 4.68e-03 | 128 | 105 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.77e-03 | 207 | 105 | 5 | GO:0008236 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 4.89e-03 | 20 | 105 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | amide binding | 5.00e-03 | 299 | 105 | 6 | GO:0033218 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 5.27e-03 | 212 | 105 | 5 | GO:0017171 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.99e-03 | 70 | 105 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.09e-03 | 138 | 105 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 6.45e-03 | 23 | 105 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.45e-03 | 23 | 105 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.73e-03 | 73 | 105 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | peptidase activity | 7.58e-03 | 654 | 105 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 7.59e-03 | 25 | 105 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 7.59e-03 | 25 | 105 | 2 | GO:0055056 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | VMP1 SLC5A10 TRPM7 BAK1 KCNAB2 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 APLNR KCNAB1 SLC37A2 TRPM1 CTNS SLC5A8 | 1.26e-05 | 1017 | 104 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | VMP1 SLC5A10 TRPM7 BAK1 KCNAB2 GRIA2 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 APLNR KCNAB1 TRPM1 CTNS | 1.92e-05 | 942 | 104 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | VMP1 SLC5A10 TRPM7 BAK1 KCNAB2 GRIA2 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 APLNR KCNAB1 TRPM1 CTNS ABCC10 | 4.06e-05 | 1115 | 104 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC2A8 SLC10A3 GRM1 SLC6A6 SLC16A4 SLC37A2 CTNS SLC5A8 SLC7A10 ABCC10 SLC27A5 | 5.81e-05 | 515 | 104 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | VMP1 SLC5A10 TRPM7 BAK1 KCNAB2 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 APLNR KCNAB1 TRPM1 CTNS | 5.87e-05 | 922 | 104 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | VMP1 SLC5A10 TRPM7 BAK1 KCNAB2 GRIA2 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 APLNR KCNAB1 TRPM1 CTNS SLC5A8 | 6.42e-05 | 1157 | 104 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | VMP1 SLC5A10 TRPM7 BAK1 KCNAB2 GRIA2 TMEM38B RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 APLNR KCNAB1 TRPM1 CTNS SLC5A8 ABCC10 | 1.64e-04 | 1374 | 104 | 18 | GO:0006811 |
| MousePheno | venoocclusion | 6.45e-06 | 7 | 81 | 3 | MP:0006137 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 3.32e-05 | 2 | 81 | 2 | MP:0009507 | |
| MousePheno | ectropion | 3.32e-05 | 2 | 81 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 3.32e-05 | 2 | 81 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 3.32e-05 | 2 | 81 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 3.32e-05 | 2 | 81 | 2 | MP:0005035 | |
| MousePheno | absent cornea epithelium | 9.91e-05 | 3 | 81 | 2 | MP:0020856 | |
| MousePheno | increased circulating fibrinogen level | 1.97e-04 | 4 | 81 | 2 | MP:0012331 | |
| MousePheno | proctitis | 1.97e-04 | 4 | 81 | 2 | MP:0003305 | |
| Domain | K_chnl_volt-dep_bsu_KCNAB-rel | 9.18e-05 | 3 | 104 | 2 | IPR005399 | |
| Domain | K_chnl_volt-dep_bsu_KCNAB | 9.18e-05 | 3 | 104 | 2 | IPR005983 | |
| Domain | Transcription_factor_COE | 1.83e-04 | 4 | 104 | 2 | IPR003523 | |
| Domain | GPCR_2_Ig-hepta-like_rcpt | 1.83e-04 | 4 | 104 | 2 | IPR008078 | |
| Domain | COE_HLH | 1.83e-04 | 4 | 104 | 2 | IPR032201 | |
| Domain | COE_DBD | 1.83e-04 | 4 | 104 | 2 | IPR032200 | |
| Domain | TRPM_tetra | 1.83e-04 | 4 | 104 | 2 | IPR032415 | |
| Domain | Transcription_factor_COE_CS | 1.83e-04 | 4 | 104 | 2 | IPR018350 | |
| Domain | COE1_HLH | 1.83e-04 | 4 | 104 | 2 | PF16423 | |
| Domain | COE1_DBD | 1.83e-04 | 4 | 104 | 2 | PF16422 | |
| Domain | TRPM_tetra | 1.83e-04 | 4 | 104 | 2 | PF16519 | |
| Domain | COE | 1.83e-04 | 4 | 104 | 2 | PS01345 | |
| Domain | Bcl2_BH2_motif_CS | 8.41e-04 | 8 | 104 | 2 | IPR020726 | |
| Domain | Bcl2_BH1_motif_CS | 8.41e-04 | 8 | 104 | 2 | IPR020717 | |
| Domain | GPS | 9.64e-04 | 35 | 104 | 3 | PF01825 | |
| Domain | GPS | 1.05e-03 | 36 | 104 | 3 | PS50221 | |
| Domain | GPS | 1.14e-03 | 37 | 104 | 3 | IPR000203 | |
| Domain | WD40_repeat_dom | 1.37e-03 | 297 | 104 | 7 | IPR017986 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.43e-03 | 40 | 104 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.43e-03 | 40 | 104 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.43e-03 | 40 | 104 | 3 | PS50227 | |
| Domain | BH1 | 1.63e-03 | 11 | 104 | 2 | PS01080 | |
| Domain | Blc2_fam | 1.63e-03 | 11 | 104 | 2 | IPR026298 | |
| Domain | NA_SOLUT_SYMP_2 | 1.95e-03 | 12 | 104 | 2 | PS00457 | |
| Domain | SSF | 1.95e-03 | 12 | 104 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 1.95e-03 | 12 | 104 | 2 | IPR001734 | |
| Domain | Bcl-2 | 1.95e-03 | 12 | 104 | 2 | PF00452 | |
| Domain | NA_SOLUT_SYMP_3 | 1.95e-03 | 12 | 104 | 2 | PS50283 | |
| Domain | BCL2_FAMILY | 2.30e-03 | 13 | 104 | 2 | PS50062 | |
| Domain | Bcl2-like | 2.30e-03 | 13 | 104 | 2 | IPR002475 | |
| Domain | BH2 | 2.30e-03 | 13 | 104 | 2 | PS01258 | |
| Domain | - | 2.61e-03 | 333 | 104 | 7 | 2.130.10.10 | |
| Domain | EamA_dom | 2.68e-03 | 14 | 104 | 2 | IPR000620 | |
| Domain | EamA | 2.68e-03 | 14 | 104 | 2 | PF00892 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.70e-03 | 335 | 104 | 7 | IPR015943 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.72e-03 | 50 | 104 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.72e-03 | 50 | 104 | 3 | PF00002 | |
| Domain | - | 3.50e-03 | 16 | 104 | 2 | 3.20.20.100 | |
| Domain | - | 3.75e-03 | 56 | 104 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 3.95e-03 | 57 | 104 | 3 | IPR023753 | |
| Domain | Kringle | 3.95e-03 | 17 | 104 | 2 | IPR000001 | |
| Domain | NADP_OxRdtase_dom | 3.95e-03 | 17 | 104 | 2 | IPR023210 | |
| Domain | Kringle_CS | 3.95e-03 | 17 | 104 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 3.95e-03 | 17 | 104 | 2 | PS50070 | |
| Domain | Kringle | 3.95e-03 | 17 | 104 | 2 | PF00051 | |
| Domain | Aldo_ket_red | 3.95e-03 | 17 | 104 | 2 | PF00248 | |
| Domain | KRINGLE_1 | 3.95e-03 | 17 | 104 | 2 | PS00021 | |
| Domain | Aldo/ket_red/Kv-b | 3.95e-03 | 17 | 104 | 2 | IPR001395 | |
| Domain | AMP-bd_C | 3.95e-03 | 17 | 104 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 3.95e-03 | 17 | 104 | 2 | PF13193 | |
| Domain | KR | 3.95e-03 | 17 | 104 | 2 | SM00130 | |
| Domain | ADAM_CR | 4.43e-03 | 18 | 104 | 2 | PF08516 | |
| Domain | GPCR_2_secretin-like | 4.56e-03 | 60 | 104 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.56e-03 | 60 | 104 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.78e-03 | 61 | 104 | 3 | PS50261 | |
| Domain | - | 5.47e-03 | 20 | 104 | 2 | 4.10.70.10 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC5A10 SLC2A8 TRPM7 AQP3 RYR3 SLC6A6 SLC9A2 SLC12A1 LPA ATP6V0A4 TRPM1 CTNS SLC5A8 SLC7A10 ABCC10 | 1.20e-05 | 736 | 79 | 15 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC5A10 SLC2A8 TRPM7 AQP3 RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 TRPM1 CTNS SLC5A8 SLC7A10 ABCC10 | 2.22e-05 | 681 | 79 | 14 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.10e-05 | 108 | 79 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.27e-05 | 109 | 79 | 6 | MM15074 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.45e-05 | 238 | 79 | 8 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 7.49e-05 | 249 | 79 | 8 | M5988 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.42e-04 | 22 | 79 | 3 | M39795 | |
| Pubmed | 4.69e-07 | 21 | 106 | 4 | 25707359 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 38820498 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31690812 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30254165 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 9819364 | |
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 9.20e-06 | 2 | 106 | 2 | 23943648 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 9.20e-06 | 2 | 106 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 9.20e-06 | 2 | 106 | 2 | 7705657 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23041318 | ||
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 9.20e-06 | 2 | 106 | 2 | 18566672 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19752236 | ||
| Pubmed | Shaker K+ channel beta subunits belong to an NAD(P)H-dependent oxidoreductase superfamily. | 9.20e-06 | 2 | 106 | 2 | 8001150 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 6216475 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 9.20e-06 | 2 | 106 | 2 | 20653841 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12428098 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 9.20e-06 | 2 | 106 | 2 | 20440070 | |
| Pubmed | Myocardial Blood Flow Control by Oxygen Sensing Vascular KvĪ² Proteins. | 9.20e-06 | 2 | 106 | 2 | 33499656 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24732409 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15720404 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 9.20e-06 | 2 | 106 | 2 | 15456492 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 9.20e-06 | 2 | 106 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 16956791 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25409527 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1543918 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8704243 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17267741 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23702659 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29990619 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17293777 | ||
| Pubmed | Localization of two potassium channel beta subunit genes, KCNA1B and KCNA2B. | 9.20e-06 | 2 | 106 | 2 | 8838324 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 9.20e-06 | 2 | 106 | 2 | 10854210 | |
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 9.20e-06 | 2 | 106 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 9.20e-06 | 2 | 106 | 2 | 22079981 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9490681 | ||
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 9.20e-06 | 2 | 106 | 2 | 9490683 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16481742 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18983515 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34378815 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 9.20e-06 | 2 | 106 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 9.20e-06 | 2 | 106 | 2 | 21239499 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10642175 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12225871 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9770530 | ||
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 9.20e-06 | 2 | 106 | 2 | 30323258 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 9.20e-06 | 2 | 106 | 2 | 37971174 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 9.20e-06 | 2 | 106 | 2 | 26473342 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10816371 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 9.20e-06 | 2 | 106 | 2 | 26791370 | |
| Pubmed | Selection of mutant Āµplasmin for amyloid-Ī² cleavage in vivo. | 9.20e-06 | 2 | 106 | 2 | 32694536 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7525077 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 9.20e-06 | 2 | 106 | 2 | 16052596 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17122079 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16103174 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21300353 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15737740 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11306011 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12149246 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22056679 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 9.20e-06 | 2 | 106 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 9.20e-06 | 2 | 106 | 2 | 21190118 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18039665 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9671388 | ||
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 9.20e-06 | 2 | 106 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 9.20e-06 | 2 | 106 | 2 | 10885855 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 9.20e-06 | 2 | 106 | 2 | 12559391 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27319402 | ||
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 9.20e-06 | 2 | 106 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 9.20e-06 | 2 | 106 | 2 | 16150044 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11916082 | ||
| Pubmed | Unaltered prion protein cleavage in plasminogen-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 16543819 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34423816 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 11500461 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12167431 | ||
| Pubmed | Impaired wound healing in mice with a disrupted plasminogen gene. | 9.20e-06 | 2 | 106 | 2 | 8612226 | |
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 9.20e-06 | 2 | 106 | 2 | 19683575 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10537128 | ||
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 9.20e-06 | 2 | 106 | 2 | 23555246 | |
| Pubmed | Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells. | 9.20e-06 | 2 | 106 | 2 | 12036889 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18685433 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31462325 | ||
| Pubmed | Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. | 9.20e-06 | 2 | 106 | 2 | 9242524 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16818777 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19273908 | ||
| Pubmed | Lactational competence and involution of the mouse mammary gland require plasminogen. | 2.76e-05 | 3 | 106 | 2 | 11003846 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9693107 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28320709 | ||
| Pubmed | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. | 2.76e-05 | 3 | 106 | 2 | 12431907 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16413499 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33827130 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24612416 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 35864199 | ||
| Pubmed | In vivo regulation of plasminogen function by plasma carboxypeptidase B. | 2.76e-05 | 3 | 106 | 2 | 12417566 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19465692 | ||
| Interaction | DEFB109B interactions | 1.26e-06 | 38 | 101 | 5 | int:DEFB109B | |
| Cytoband | 5q32 | 2.72e-04 | 54 | 106 | 3 | 5q32 | |
| Cytoband | 15q21 | 2.87e-04 | 11 | 106 | 2 | 15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 6.20e-04 | 16 | 106 | 2 | chr6q26 | |
| Cytoband | 6q26 | 7.89e-04 | 18 | 106 | 2 | 6q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 8.64e-04 | 80 | 106 | 3 | chr5q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 1.64e-03 | 100 | 106 | 3 | chr15q13 | |
| Cytoband | 19p13.3 | 2.28e-03 | 237 | 106 | 4 | 19p13.3 | |
| Cytoband | 12q23.1 | 2.66e-03 | 33 | 106 | 2 | 12q23.1 | |
| Cytoband | 6p12.3 | 3.16e-03 | 36 | 106 | 2 | 6p12.3 | |
| GeneFamily | Solute carriers | SLC5A10 SLC2A8 SLC10A3 SLC35G4 SLC6A6 SLC9A2 SLC12A1 SLC16A4 SLC35G5 SLC37A2 SLC5A8 SLC7A10 SLC27A5 | 7.89e-09 | 395 | 75 | 13 | 752 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily F | 1.68e-04 | 5 | 75 | 2 | 916 | |
| GeneFamily | BCL2 family | 1.50e-03 | 14 | 75 | 2 | 1057 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 1.72e-03 | 15 | 75 | 2 | 858 | |
| GeneFamily | Aldo-keto reductases | 1.72e-03 | 15 | 75 | 2 | 399 | |
| GeneFamily | Acyl-CoA synthetase family | 5.17e-03 | 26 | 75 | 2 | 40 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.57e-03 | 27 | 75 | 2 | 47 | |
| GeneFamily | Transient receptor potential cation channels | 5.99e-03 | 28 | 75 | 2 | 249 | |
| GeneFamily | CD molecules|Tetraspanins | 8.25e-03 | 33 | 75 | 2 | 768 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-07 | 190 | 106 | 7 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-07 | 191 | 106 | 7 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 192 | 106 | 7 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-07 | 194 | 106 | 7 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.10e-06 | 168 | 106 | 6 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.32e-06 | 170 | 106 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 178 | 106 | 6 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-06 | 182 | 106 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-06 | 187 | 106 | 6 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.93e-06 | 188 | 106 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.11e-06 | 189 | 106 | 6 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | 45929c757d873fe314cc36d27abd265414635490 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | beb336d3479821bdab7e8e2c58812f155e44e9a2 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 194 | 106 | 6 | f6c9cc362ccdbc7e790f7c8d1c56cab3557c5306 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.30e-06 | 195 | 106 | 6 | cd011433b3b9bfb1adb13eca2f3f2a5db024cd94 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.74e-06 | 197 | 106 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.97e-06 | 198 | 106 | 6 | 7063d74d79f53d5c59c853a2575f9d3ef12f19ea | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 127 | 106 | 5 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.88e-05 | 149 | 106 | 5 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.88e-05 | 149 | 106 | 5 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-05 | 155 | 106 | 5 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.21e-05 | 81 | 106 | 4 | c9145c994abcf49e5492270b18b0580a3d771ccf | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.21e-05 | 81 | 106 | 4 | 34d2a2c30c749bd2ad447dfb1e43444953d9b154 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.21e-05 | 81 | 106 | 4 | f84bfa55c6b9548f8829b16a145690d207a7bfc1 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.56e-05 | 164 | 106 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-05 | 167 | 106 | 5 | 166b7b4ca0663cde6d88219ee0bcc1988d03dab8 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.71e-05 | 172 | 106 | 5 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.87e-05 | 173 | 106 | 5 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.87e-05 | 173 | 106 | 5 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-05 | 174 | 106 | 5 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-05 | 174 | 106 | 5 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-05 | 174 | 106 | 5 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 175 | 106 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 175 | 106 | 5 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 175 | 106 | 5 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | ac3dc44755280e36c0947b6de3cd639dc17de8b6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 177 | 106 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 6.55e-05 | 177 | 106 | 5 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 177 | 106 | 5 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.55e-05 | 177 | 106 | 5 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 177 | 106 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.90e-05 | 179 | 106 | 5 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-05 | 179 | 106 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 180 | 106 | 5 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 180 | 106 | 5 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.09e-05 | 180 | 106 | 5 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.09e-05 | 180 | 106 | 5 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-05 | 181 | 106 | 5 | 46c428037b6eac605635e20e8cc78bce744b4daa | |
| ToppCell | Healthy-B_memory|Healthy / disease group, cell group and cell class | 7.27e-05 | 181 | 106 | 5 | 7b903076efb90026b9845af0c7a840901451193a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.27e-05 | 181 | 106 | 5 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 7.47e-05 | 182 | 106 | 5 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 182 | 106 | 5 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-05 | 183 | 106 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 9f8cd5ab5af6c35a1be25d70a125b9a3f4dd667a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.86e-05 | 184 | 106 | 5 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 8.06e-05 | 185 | 106 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-05 | 185 | 106 | 5 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.06e-05 | 185 | 106 | 5 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 8.06e-05 | 185 | 106 | 5 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-05 | 186 | 106 | 5 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 186 | 106 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.27e-05 | 186 | 106 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.48e-05 | 187 | 106 | 5 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 187 | 106 | 5 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 187 | 106 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 8.48e-05 | 187 | 106 | 5 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 187 | 106 | 5 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-05 | 187 | 106 | 5 | 6cf7be5401b81a4eeb30840fb3733d61a24af539 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 187 | 106 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 187 | 106 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 187 | 106 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 187 | 106 | 5 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 187 | 106 | 5 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-05 | 187 | 106 | 5 | 63834420db930df91b62494c9d7aaa9a25bca530 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.70e-05 | 188 | 106 | 5 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 188 | 106 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 189 | 106 | 5 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.92e-05 | 189 | 106 | 5 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.14e-05 | 190 | 106 | 5 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| Drug | sodium | SLC5A10 SLC2A8 TRPM7 KCNAB2 GRIA2 BCHE SLC10A3 F3 AQP3 RYR3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 KCNAB1 ACTL6B TRPM1 SLC5A8 SLC7A10 | 3.51e-08 | 944 | 102 | 19 | CID000000923 |
| Drug | ogen | 1.94e-06 | 46 | 102 | 5 | CID000023703 | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.87e-06 | 196 | 102 | 8 | 3305_UP | |
| Drug | CHEBI:564108 | 3.02e-06 | 7 | 102 | 3 | CID006400637 | |
| Drug | 2-cyanoacetamide | 8.50e-06 | 162 | 102 | 7 | CID000007898 | |
| Drug | Gly-pro-arg | 1.24e-05 | 32 | 102 | 4 | CID000170776 | |
| Drug | V of 3 | 1.99e-05 | 2 | 102 | 2 | CID000123322 | |
| Drug | magnesium | TRPM7 ACSS1 GRIA2 BCHE ITGA2 ADGRV1 GRM1 POLA2 F3 AQP3 RYR3 ARL4D ITPKB SLC12A1 ATP6V0A4 SERGEF ACTL6B TRPM1 | 2.23e-05 | 1325 | 102 | 18 | CID000000888 |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.31e-05 | 189 | 102 | 7 | 6954_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.64e-05 | 193 | 102 | 7 | 4713_UP | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 2425_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 5495_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3098_UP | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; HL60; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3065_UP | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 3419_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 7327_UP | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 7380_UP | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 2797_UP | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 7066_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 5975_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 6929_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 4013_DN | |
| Drug | bumetanide | 4.39e-05 | 209 | 102 | 7 | CID000002471 | |
| Drug | chloride | SLC5A10 ASPG ACSS1 BCHE ITGA2 GRM1 F3 AQP3 SLC6A6 SLC9A2 SLC12A1 ATP6V0A4 ACTL6B PLG SLC7A10 | 5.31e-05 | 1029 | 102 | 15 | CID000000312 |
| Drug | Aminocaproic Acid | 5.94e-05 | 3 | 102 | 2 | DB00513 | |
| Drug | voachalotine | 5.94e-05 | 3 | 102 | 2 | CID000099116 | |
| Drug | Propionates | 5.94e-05 | 3 | 102 | 2 | ctd:D011422 | |
| Drug | o-xylylene | 5.94e-05 | 3 | 102 | 2 | CID000141735 | |
| Drug | nostocarboline | 5.94e-05 | 3 | 102 | 2 | CID005326150 | |
| Drug | NSC628058 | 5.94e-05 | 3 | 102 | 2 | CID000431073 | |
| Drug | glycolamide | 5.94e-05 | 3 | 102 | 2 | CID000069021 | |
| Drug | LY382884 | 8.03e-05 | 19 | 102 | 3 | CID000656723 | |
| Drug | tetramethylammonium | 9.39e-05 | 53 | 102 | 4 | CID000006380 | |
| Drug | butyphos | 1.19e-04 | 4 | 102 | 2 | CID000013138 | |
| Drug | distigmine bromide | 1.19e-04 | 4 | 102 | 2 | CID000003116 | |
| Drug | methyl-methylcarbamate | 1.19e-04 | 4 | 102 | 2 | CID000081151 | |
| Drug | OMS-22 | 1.19e-04 | 4 | 102 | 2 | CID000019107 | |
| Drug | 4-Formyl-trans-stilbene | 1.19e-04 | 4 | 102 | 2 | CID000141711 | |
| Drug | bromoacetamide | 1.19e-04 | 4 | 102 | 2 | CID000069632 | |
| Drug | hypophosphoric acid | 1.19e-04 | 4 | 102 | 2 | CID000024536 | |
| Drug | methanesulfonate | 1.25e-04 | 57 | 102 | 4 | CID000006395 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.57e-04 | 179 | 102 | 6 | 4541_UP | |
| Drug | melatonin | 1.71e-04 | 443 | 102 | 9 | CID000000896 | |
| Drug | tranexamic acid | 1.96e-04 | 64 | 102 | 4 | CID000005526 | |
| Drug | Malformin A | 1.97e-04 | 5 | 102 | 2 | CID000004005 | |
| Drug | 4-carbethoxyhexafluorobutyryl chloride | 1.97e-04 | 5 | 102 | 2 | CID000161251 | |
| Drug | phenethyl bromide | 1.97e-04 | 5 | 102 | 2 | CID000007666 | |
| Drug | dioxacarb | 1.97e-04 | 5 | 102 | 2 | CID000023421 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.99e-04 | 187 | 102 | 6 | 5420_UP | |
| Drug | NSC9564 | 2.08e-04 | 65 | 102 | 4 | CID000004536 | |
| Drug | 1pyn | 2.11e-04 | 26 | 102 | 3 | CID000447968 | |
| Drug | GW8510; Up 200; 10uM; MCF7; HT_HG-U133A | 2.29e-04 | 192 | 102 | 6 | 7062_UP | |
| Drug | GW8510; Up 200; 10uM; MCF7; HT_HG-U133A | 2.35e-04 | 193 | 102 | 6 | 7080_UP | |
| Drug | Cocaine | PCSK2 GRIA2 BCHE GRM1 RYR3 MAPK8IP3 ITPKB KLHL5 SLC9A2 SLC12A1 APLNR KCNAB1 CTRL QTRT1 ADGRF1 SORL1 | 2.38e-04 | 1314 | 102 | 16 | ctd:D003042 |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 4371_UP | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 3301_UP | |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 3379_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; HL60; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 2940_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 4384_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 3669_UP | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 4111_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 7226_DN | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4206_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4256_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 5407_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4484_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4479_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 6655_UP | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 4075_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 5341_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 4318_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 3350_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 5076_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 2427_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 4088_UP | |
| Drug | aptiganel | 2.64e-04 | 28 | 102 | 3 | CID000060839 | |
| Drug | tri-n-butylborane | 2.64e-04 | 28 | 102 | 3 | CID000031216 | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 4505_UP | |
| Drug | Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 2178_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 3128_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 4695_UP | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 3324_UP | |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 3289_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 2542_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; PC3; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 3987_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 7357_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 6001_DN | |
| Drug | Prostaglandin E1; Down 200; 10uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 6576_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 4812_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 5002_UP | |
| Drug | N-acetylhexosamine | 2.73e-04 | 472 | 102 | 9 | CID000000899 | |
| Drug | Thiethylperazine malate [52239-63-1]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 3576_UP | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 6686_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 5006_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; HL60; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 3067_DN | |
| Drug | gadolinium | 2.78e-04 | 199 | 102 | 6 | CID000023982 | |
| Drug | Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 5623_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; HL60; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 1322_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; HL60; HT_HG-U133A | 2.85e-04 | 200 | 102 | 6 | 2963_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.85e-04 | 200 | 102 | 6 | 4740_UP | |
| Disease | lifestyle measurement, alcohol consumption measurement | 5.08e-05 | 115 | 102 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | Deep Vein Thrombosis | 5.10e-05 | 21 | 102 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 5.10e-05 | 21 | 102 | 3 | C0042487 | |
| Disease | plasma plasminogen measurement | 1.18e-04 | 5 | 102 | 2 | EFO_0006309 | |
| Disease | Smith-McCort dysplasia (implicated_via_orthology) | 1.18e-04 | 5 | 102 | 2 | DOID:0060247 (implicated_via_orthology) | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 1.18e-04 | 5 | 102 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | Epileptic encephalopathy | 1.52e-04 | 30 | 102 | 3 | C0543888 | |
| Disease | familial hyperlipidemia (is_marker_for) | 1.76e-04 | 6 | 102 | 2 | DOID:1168 (is_marker_for) | |
| Disease | angiostatin measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0008024 | |
| Disease | MASA syndrome (implicated_via_orthology) | 2.46e-04 | 7 | 102 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 3.61e-04 | 40 | 102 | 3 | EFO_0004746 | |
| Disease | interleukin 2 measurement | 3.89e-04 | 41 | 102 | 3 | EFO_0008331 | |
| Disease | Todd Paralysis | 4.19e-04 | 9 | 102 | 2 | C0234544 | |
| Disease | Paralysed | 4.19e-04 | 9 | 102 | 2 | C0522224 | |
| Disease | premature birth | 4.19e-04 | 9 | 102 | 2 | EFO_0003917 | |
| Disease | monocyte count | VMP1 FCRL2 TRPM7 EBF1 XPNPEP2 ADGRV1 KLHL5 LPA ZMIZ2 ZC3HAV1L PLG SLC7A10 SORL1 | 6.27e-04 | 1320 | 102 | 13 | EFO_0005091 |
| Disease | Schizophrenia | 9.75e-04 | 883 | 102 | 10 | C0036341 | |
| Disease | serum albumin measurement | 1.05e-03 | 592 | 102 | 8 | EFO_0004535 | |
| Disease | uric acid measurement | 1.27e-03 | 610 | 102 | 8 | EFO_0004761 | |
| Disease | cutaneous Leishmaniasis | 1.38e-03 | 16 | 102 | 2 | EFO_0005046 | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 1.38e-03 | 16 | 102 | 2 | EFO_0801688 | |
| Disease | non-word reading | 1.64e-03 | 67 | 102 | 3 | EFO_0005299 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.99e-03 | 153 | 102 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | COVID-19 (is_implicated_in) | 2.38e-03 | 21 | 102 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | apolipoprotein A 1 measurement | 2.72e-03 | 848 | 102 | 9 | EFO_0004614 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTTGWGRLSGVGNVT | 156 | P40313 | |
| QGSWTGFVGEDLVTI | 151 | Q9Y5Z0 | |
| STGKIGWFLGGQLNV | 96 | Q9NUB1 | |
| AVSGVGIWIAFTSGS | 1116 | O15013 | |
| TVLIWIYGGGFQTGT | 136 | P06276 | |
| AILVAAIVLGGTGWG | 801 | O75077 | |
| GSRGITFQVWDVGGQ | 66 | P49703 | |
| GPTWGRVVTLVTFAG | 91 | Q9HD36 | |
| SGINWGRVVALLGFG | 121 | Q16611 | |
| SVGLALFVWVLGGGV | 71 | Q9NS82 | |
| LFVWVLGGGVTALGS | 76 | Q9NS82 | |
| GLTWGFGIGTIVDSQ | 801 | Q5T601 | |
| IGRTINGTFFGGWKS | 316 | P08319 | |
| HGSLEGGFGIWNTAV | 401 | Q5FYB1 | |
| WIGGSILASLGTFQQ | 391 | O94805 | |
| LTWGFGIATLIEGTS | 616 | Q8IZF3 | |
| GVFGDVQLGWEILSS | 1276 | Q8WXG9 | |
| VAAIVLGGTGWGFKN | 746 | O75078 | |
| GEILGVVVVESGWGS | 576 | Q99767 | |
| ASGVSWVGEEAIGGS | 1251 | Q5H9R4 | |
| SENVDISSGGGVTGW | 181 | P61026 | |
| GFVWLQSVATVAGSG | 376 | Q99742 | |
| AWEVGLGVSSTTVGF | 196 | P35414 | |
| LGTGWLTQGGVEFQD | 1236 | Q5T3U5 | |
| SAWAGLRGTGQVGIS | 366 | Q13477 | |
| LVAGSRLWVGTGNGV | 1151 | Q9UPT6 | |
| RVWILGSNGFAVGEG | 426 | Q2M2H8 | |
| SLQGNTLGGGVSWLL | 371 | Q86U10 | |
| VSCLGLGTWVTFGGQ | 101 | Q14722 | |
| LGTWVTFGGQISDEV | 106 | Q14722 | |
| GSTALVGWITGAAVA | 6 | Q6UXD1 | |
| WGLIFGVSSNSIQIG | 16 | P42262 | |
| SLAGAQGSLWSVEGG | 231 | Q8NBM8 | |
| TGSSWAFGIIDGVIQ | 146 | Q8NHB1 | |
| TGSSWAFGIIDGLIQ | 146 | Q96R30 | |
| SAITWGGGGGFVVSI | 121 | P09131 | |
| ISWNGFVGGTLLSIT | 121 | Q6UY01 | |
| LGVEIHWGVTFTGLQ | 171 | Q8TDZ2 | |
| GGVGVTTWNGLLYAI | 646 | Q96PQ7 | |
| LGAVGAFGWSGTIVQ | 396 | P17301 | |
| FSLSTSGVGVGWIRQ | 46 | P01817 | |
| CLGLGTWVTFGGQIT | 51 | Q13303 | |
| LWALQGGTSVVIANG | 316 | P54886 | |
| QVLTTGGGWQDQVGG | 876 | Q8N0W3 | |
| GNILGSLIAGIWVNG | 191 | Q8TED4 | |
| SGVATGLWTVFTLGG | 251 | Q7RTS9 | |
| GWTTGGATVIVIGDN | 266 | Q9BQW3 | |
| VRVGGGWDTLQGFLL | 261 | Q86XJ1 | |
| VTLESGGSGGVVWRI | 661 | Q969H0 | |
| FTALRVWGVGNEAGV | 31 | Q53GQ0 | |
| TPLLGLTWGFGVATV | 656 | Q8IZF7 | |
| TGWGETQGTFGTGLL | 1941 | P08519 | |
| QAWALVGVIDGGSTS | 346 | Q9UHN6 | |
| EGWTTGGATVIIIGD | 271 | Q9UH73 | |
| GETVALGASGIVIWG | 326 | P38567 | |
| GWSIGNVLLDFTGGS | 296 | O60931 | |
| VLWGLFGVLGFTGVA | 401 | Q96LA5 | |
| LGVVGEFSLIGSDGW | 306 | Q13255 | |
| FVLTVIQAIGFSGWG | 116 | Q969E2 | |
| FVGWVAGGLTLIGGV | 176 | P56856 | |
| WSVQDGGSGSEIGVF | 261 | Q9Y597 | |
| GFLGTVAGLVTGWSL | 111 | P03999 | |
| GLWTLQEGTTGVYTT | 176 | Q96KT7 | |
| TWGDHGGIITAIAQG | 541 | Q92673 | |
| VAATASGIVFQWGTG | 166 | Q9UGK8 | |
| VSGGSAEGISNSVWG | 236 | Q9HCJ0 | |
| VLSVAGGFVGLGNVW | 51 | P31641 | |
| AIGGLSGGESKSQFW | 226 | Q9BXR0 | |
| TITAIVQTGGGWSTG | 61 | A1L4L8 | |
| AGLAWTRGTGVQSEG | 516 | P27987 | |
| WFGAVVTLGAAAGGV | 71 | Q9NY64 | |
| AWGSGVEVLVSVLVG | 81 | P03923 | |
| VIWGFGTPGATVTVT | 46 | Q9HAT2 | |
| QVTGFDLWGAVVATG | 156 | Q8N695 | |
| SWIVGEAGIGLGVLI | 201 | Q13621 | |
| SFEKGQGVLIGNWTG | 221 | P49221 | |
| VTSFGLAQGVSWSGR | 171 | Q14181 | |
| ITGWGETQGTFGAGL | 701 | P00747 | |
| TGLHTGWIQNGGLFI | 141 | Q9UL12 | |
| TALAGWGSAVFTTGQ | 226 | Q92482 | |
| GTTFNGWFEIIGNGS | 131 | Q6UVW9 | |
| GLWTLQEGTTGVYTG | 176 | P0C7Q5 | |
| SWPVVGQFSSVGSLG | 391 | Q9NUW8 | |
| GGTAVTGGQTVVNPW | 206 | Q99611 | |
| VVAWGTGQVGLGGEV | 481 | Q96KV7 | |
| EGQVIATGSWAGSIS | 1811 | Q99973 | |
| EFEGTSEQIGWIGSI | 51 | O15374 | |
| GTLWNSIGIGVSLFG | 176 | Q9UBY0 | |
| GAFWGLIAGLVVGAT | 471 | A0PJK1 | |
| ALLVWTGPGAGSVTF | 131 | Q9Y2P5 | |
| WSTVFGGGLVEGAKN | 4211 | Q15413 | |
| AIGWARGAGGTIITN | 146 | Q9NVV0 | |
| VGSGSGRNLWVSGLS | 401 | Q14151 | |
| LLGWVFAQVAGASGT | 21 | P13726 | |
| GWSQGTEGSLIIALG | 371 | Q9P2J2 | |
| QIGGSFAVWGGLFST | 61 | O60830 | |
| WSSFVGGGVLTLLVE | 131 | Q96CP7 | |
| AGSLSVVTTVWGVGN | 36 | Q8NF64 | |
| TGAWIFTGGVSTGVI | 131 | Q7Z4N2 | |
| GLQTRGWGGIVGVFI | 766 | Q9HBG4 | |
| GVLGVGIWLAATQGS | 26 | O14817 | |
| WITGFTGSAGTAVVT | 91 | O43895 | |
| WKQEGVVGSESGSFL | 21 | Q6P3X3 | |
| GAVVTWVIELGGTGL | 131 | Q6ZQQ6 | |
| TTGAWILTGGVNTGV | 166 | Q96QT4 | |
| ALSEGISFWGQLTQG | 101 | Q5CZA5 | |
| GLLGVGIWLSVSQGN | 26 | O75954 | |
| AVGGGGTSAWRVVAV | 71 | Q96H79 | |
| WIGLGILSSVGLGTG | 116 | Q96GC9 | |
| GTWTLELGFVGSAPQ | 566 | P16519 |